I Win SB 130mg Capsule contains Itraconazole, a broad-spectrum antifungal agent used for the treatment of various fungal infections. Itraconazole belongs to the triazole class of antifungals and works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting fungal cell growth and replication. This medication is indicated for the management of systemic and superficial mycoses, including aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and other dermatophytic infections. I Win SB 130mg Capsule is administered orally and should be taken as prescribed by a healthcare professional, typically with food to enhance absorption. The dosage and duration of therapy depend on the type and severity of the infection. Common adverse effects may include gastrointestinal disturbances such as nausea, vomiting, abdominal pain, and diarrhea, as well as headache and dizziness. Caution is advised in patients with hepatic impairment or congestive heart failure, and potential drug interactions should be reviewed due to itraconazole’s effect on cytochrome P450 enzymes. Regular monitoring of liver function tests is recommended during prolonged therapy. I Win SB 130mg Capsule should be used under medical supervision to ensure optimal efficacy and safety.